Mega Cap Healthcare
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Eli Lilly
LLY
$1.03T
| $1.03T | $1,152.44 | 1.28% |
|
2
Johnson & Johnson
JNJ
$651B
| $651B | $270.22 | 1.1% |
|
3
AbbVie
ABBV
$467B
| $467B | $264.02 | 0.58% |
|
4
Merck
MRK
$363B
| $363B | $147.15 | 1.55% |
|
5
UnitedHealth
UNH
$337B
| $337B | $375.21 | 0.01% |
|
6
Novartis
NVS
$268B
| $268B | $140.92 | 1.6% |
|
7
AstraZeneca
AZN
$258B
| $258B | $166.14 | 2% |
|
8
Thermo Fisher Scientific
TMO
$243B
| $243B | $658.32 | 1.53% |
|
9
Amgen
AMGN
$205B
| $205B | $379.78 | 0.91% |
|
Mega Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 9 mega cap Healthcare stocks — companies in the Healthcare sector with a market cap over $200B — worth a combined $3.82T.
The largest by market cap are Eli Lilly (LLY) at $1.03T, Johnson & Johnson (JNJ) at $651B and AbbVie (ABBV) at $467B.
Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 525 funds opened new positions, taking total fund holders up 335 (11%) quarter-over-quarter.
- Combined market cap: $3.82T across 9 stocks.
- Mega Cap: market cap over $200B.
- Largest constituent: Eli Lilly (LLY), $1.03T market cap.
- Most net new fund positions in Q2 2026: UnitedHealth (UNH), +335 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.